Gilead Sciences has not commented on a report indicating positive results for a medication aimed at treating the coronavirus (AFP Photo/Olivier DOULIERY)More

New York (AFP) – Shares of US drugmaker Gilead Sciences rocketed higher Friday following a report recounting a promising performance for an antiviral medication being tested to treat the coronavirus.

The report in Stat News described a video discussion in which the head of clinical trials at the University of Chicago Medical School said almost all of the patients in a research group had been discharged after being treated with Gilead’s remdesivir.

The group of 125 patients, most with severe COVID-19 symptoms, suffered just two fatalities, Stat reported.

Gilead told the health news website that it would comment when more data is available.

The California-based company’s